Research and Markets has announced the addition of the "Asia Pacific Autoimmune Disorders Treatment Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
Key market players of Asia pacific autoimmune disorders treatment market includes, Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Johnson & Johnson, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Sanofi, Merck, and Pfizer Inc. Recently, Abbott has announced Thyroid Awareness Initiative in India, which aimed at greater understanding of thyroid disorder that would amplify the access to its diagnosis.
KEY TAKE AWAYS
AUTOIMMUNE DISORDERS TREATMENT MARKET KEY SEGMENTS
BY PRODUCT TYPE
Therapeutic drug Products
For more information about this report visit http://www.researchandmarkets.com/research/2l6jgd/asia_pacific
View source version on businesswire.com: http://www.businesswire.com/news/home/20161116005779/en/Business Wire
Last updated on: 16/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.